ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

HZD Horizon Discovery Group Plc

184.50
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Horizon Discovery Group Plc LSE:HZD London Ordinary Share GB00BK8FL363 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 184.50 184.50 185.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Horizon Discovery Group plc Block Listing Six Monthly Return (7051V)

26/07/2018 9:01am

UK Regulatory


Horizon Discovery (LSE:HZD)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Horizon Discovery Charts.

TIDMHZD

RNS Number : 7051V

Horizon Discovery Group plc

26 July 2018

Horizon Discovery Group plc

Block Listing Six Monthly Return and Block Listing Application

26 July 2018

Horizon Discovery Group plc (LSE: HZD) ("Horizon") provides the following update in accordance with Schedule Six of the AIM Rules for Companies regarding its existing block listing arrangements:

 
 Name of applicant:                 Horizon Discovery Group plc 
 Name of scheme(s):                 a) Horizon Discovery Limited Enterprise 
                                     Management Incentive Share Option 
                                     Scheme 
                                     b) Horizon Discovery Group plc Long 
                                     Term Incentive Plan 
                                     c) Horizon Discovery 2014 Sharesave 
                                     Scheme 
                                     d) Horizon Discovery Group plc US 
                                     Employee Stock Purchase Plan 
                                   ------------------------------------------ 
 Period of return (from /           From: 27 January      To: 26 July 2018 
  to):                               2018 
                                   --------------------  -------------------- 
 Number of securities originally    Total of 3,000,000 ordinary shares 
  admitted and date of admission     of 1p each, split: 
                                     a) 1,398,000 
                                     b) 1,392,000 
                                     c) 110,000 
                                     d) 100,000 
                                     Admission date 26 July 2017 
                                   ------------------------------------------ 
 Balance of unallotted securities   Total of 2,574,510 ordinary shares 
  under schemes from previous        of 1p each, split 
  return:                            a) 1,177,344 
                                     b) 1,306,640 
                                     c) 24,671 
                                     d) 65,855 
                                   ------------------------------------------ 
 Plus: The amount by which          Total of 500,000 ordinary shares 
  the block scheme(s) has been       of 1p each, split 
  increased or application           a) 0 
  has been made to increase          b) 150,000 
  since the date of the last         c) 150,000 
  return (if any increase has        d) 200,000 
  been applied for):                 As applied for in the below paragraph. 
                                   ------------------------------------------ 
 Less: Number of securities         Total of 498,653 ordinary shares 
  issued/allotted under scheme(s)    of 1p each, split 
  during period:                     a) 398,808 
                                     b) 82,951 
                                     c) 16,894 
                                     d) 0 
                                   ------------------------------------------ 
 Equals: Balance under scheme(s)    Total of 2,575,857 ordinary shares 
  not yet issued/allotted at         of 1p each, split 
  end of period:                     a) 778,536 
                                     b) 1,373,689 
                                     c) 157,777 
                                     d) 265,855 
                                   ------------------------------------------ 
 

BLOCK LISTING APPLICATION

Horizon announces that an application has today been made to the London Stock Exchange for the admission of 500,000 Ordinary Shares of 1 pence each (the "Ordinary Shares") in the Company under the Company's existing block listing scheme. These Ordinary Shares will be available to satisfy future exercises of options in accordance with the following employee share plans:

   --     Horizon Discovery Group plc Long Term Incentive Plan (up to 150,000 shares) 
   --     Horizon Discovery 2014 Sharesave Scheme (up to 150,000 shares) 
   --     Horizon Discovery Group plc US Employee Stock Purchase Plan (up to 200,000 shares) 

It is expected that Admission will occur on 27 July 2018. When issued, these Ordinary Shares will rank pari passu with the existing Ordinary Shares.

ENDS

For further information from Horizon Discovery Group plc, please contact:

Horizon Discovery Group plc

Ian Gilham, Executive Chairman

Terry Pizzie, Chief Executive Officer

Richard Vellacott, Chief Financial Officer

Tel: +44 (0) 1223 655 580

Numis Securities Limited (Broker and NOMAD)

Michael Meade / Freddie Barnfield

Tel: +44 (0) 207 260 1000

Consilium Strategic Communications (Financial Media and Investor Relations)

Mary-Jane Elliott / Matthew Neal / Melissa Gardiner

Tel: +44 (0) 20 3709 5700

Email: horizon@consilium-comms.com

About Horizon Discovery Group plc www.horizondiscovery.com

Horizon Discovery Group plc (LSE: HZD) ("Horizon") is a world leader in gene editing and gene modulation technologies. Horizon designs and engineers cells using its translational genomics platform, a highly precise and flexible suite of DNA editing tools (rAAV, ZFN, CRISPR and Transposon) and, following the acquisition of Dharmacon, Inc., its functional genomics platform comprising gene knockdown (RNAi) and gene expression (cDNA, ORF) tools, for research and clinical applications that advance human health. Horizon's platforms and capabilities enable researchers to alter almost any gene or modulate its function in human or mammalian cell-lines.

Horizon offers an extensive range of catalogue products and related research services to support a greater understanding of the function of genes across all species and the genetic drivers of human disease and the development of personalised molecular, cell and gene therapies. These have been adopted by over 10,000 academic, drug discovery, drug manufacturing and clinical diagnostics customers around the globe, as well as in the Company's own R&D pipeline.

Horizon is headquartered in Cambridge, UK, and is listed on the London Stock Exchange's AIM market under the ticker "HZD".

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

BLRFKPDKFBKKOOB

(END) Dow Jones Newswires

July 26, 2018 04:01 ET (08:01 GMT)

1 Year Horizon Discovery Chart

1 Year Horizon Discovery Chart

1 Month Horizon Discovery Chart

1 Month Horizon Discovery Chart

Your Recent History

Delayed Upgrade Clock